The counter opened at Rs 712.6 and touched an intraday high and low of Rs 717.8 and Rs 705.85, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1063.75 and a 52-week low of Rs 660.1.
As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 41918.05 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 5783.29 crore for the quarter ended 30-Jun-2021, down 4.87 per cent from previous quarter’s Rs 6079.6 crore and down 4.26 per cent from the year-ago quarter’s Rs 6040.37 crore.
The net profit for latest quarter stood at Rs 769.97 crore, down 1.36 per cent from the corresponding quarter last year.
Shareholding pattern
As of 30-Jun-2021, DIIs held 9.03 per cent stake in the firm, while foreign institutional investors held 23.7 per cent and the promoters 48.76 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 7.87 and a price-to-book ratio of 2.36. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma – Indian industry.
